Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Quan Capital
AddedFeb 13, 2024
UpdatedJul 16, 2026
Quan Capital

Quan Capital

Operating

Quan Capital: A venture capital firm incubating next-gen life sciences companies for healthcare solutions.

Location
Shanghai, Shanghai, CN
Founded
2017
Firm
Compare
Portfolio
Employees
Website

Investments

Adcentrx Therapeutics
Adcentrx Therapeutics

Total Raised

$101M

Rounds

2

Series A$51MApril 2023
Walking Fish Therapeutics
Walking Fish Therapeutics

Total Raised

$73M

Rounds

2

Series A$50MSeptember 2021
Interius BioTherapeutics
Interius BioTherapeutics

Total Raised

$103M

Rounds

3

Series A$76MMay 2021
Kira Pharmaceuticals
Kira Pharmaceuticals

Total Raised

$99.5M

Rounds

5

Series B$53.5MJanuary 2021
Series UnknownNovember 2020
Citrine Medicine
Citrine Medicine

Total Raised

$80M

Rounds

1

Series A$80MJuly 2020
NextCure
NextCure
Public

Total Raised

$310M

Rounds

5

Series B$93MNovember 2018
Tempest Therapeutics
Tempest Therapeutics
Acquired

Total Raised

$90M

Rounds

4

Series B$70MMarch 2018
Centrexion Therapeutics
Centrexion Therapeutics
Public

Total Raised

$229.2M

Rounds

12

Series D$67MJanuary 2018